Literature DB >> 8387030

Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus.

H Kido1, K Sakai, Y Kishino, M Tashiro.   

Abstract

The pathogenicities of influenza viruses and paramyxoviruses have been proposed to be primarily determined by a host cell protease(s) that activates viral infectivity by proteolytic cleavage of the envelope glycoproteins. We recently isolated a trypsin-type endoprotease, named tryptase Clara, from rat bronchial and bronchiolar epithelial Clara cells, which is secreted into the airway lumen and activates Sendai virus and influenza A virus proteolytically. We report here that surfactant in the bronchial fluid inhibited tryptase Clara specifically, having a Ki value of 0.13 microM, and inhibited the proteolytic activations by tryptase Clara in vitro and in organ cultures of rat lung. Intranasal infection of rats with Sendai virus was shown to stimulate secretion of tryptase Clara without changing the amount of surfactant in the bronchial lumen, resulting in a preferable condition for proteolytic viral activation and multiplication.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387030     DOI: 10.1016/0014-5793(93)81549-f

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  The requirement of reactive oxygen intermediates for lymphocytic choriomeningitis virus binding and growth.

Authors:  Ryan D Michalek; S Troy Pellom; Beth C Holbrook; Jason M Grayson
Journal:  Virology       Date:  2008-08-08       Impact factor: 3.616

2.  Kallistatin ameliorates influenza virus pathogenesis by inhibition of kallikrein-related peptidase 1-mediated cleavage of viral hemagglutinin.

Authors:  Chia-Hsing Leu; Mei-Lin Yang; Nai-Hui Chung; Yen-Jang Huang; Yu-Chu Su; Yi-Cheng Chen; Chia-Cheng Lin; Gia-Shing Shieh; Meng-Ya Chang; Shainn-Wei Wang; Yao Chang; Julie Chao; Lee Chao; Chao-Liang Wu; Ai-Li Shiau
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

3.  Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases.

Authors:  Oleg P Zhirnov; Mine R Ikizler; Peter F Wright
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

4.  Inhibitory effect of pulmonary surfactant on Sendai virus infection in rat lungs.

Authors:  M Tashiro; Y Beppu; K Sakai; H Kido
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Novel hemagglutinin-based influenza virus inhibitors.

Authors:  Xintian Shen; Xuanxuan Zhang; Shuwen Liu
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

6.  Lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome.

Authors:  Parker S Woods; Lauren M Doolittle; Lucia E Rosas; Lisa M Joseph; Edward P Calomeni; Ian C Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-11-11       Impact factor: 6.011

Review 7.  Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines.

Authors:  Shibo Jiang; Runming Li; Lanying Du; Shuwen Liu
Journal:  Protein Cell       Date:  2010-05-08       Impact factor: 14.870

Review 8.  Influenza A virus entry inhibitors targeting the hemagglutinin.

Authors:  Jie Yang; Minmin Li; Xintian Shen; Shuwen Liu
Journal:  Viruses       Date:  2013-01-22       Impact factor: 5.048

9.  Isolation of recombinant phage antibodies targeting the hemagglutinin cleavage site of highly pathogenic avian influenza virus.

Authors:  Jinhua Dong; Akira Sakurai; Namiko Nomura; Enoch Y Park; Futoshi Shibasaki; Hiroshi Ueda
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

Review 10.  RNA Viruses: ROS-Mediated Cell Death.

Authors:  Mohammad Latif Reshi; Yi-Che Su; Jiann-Ruey Hong
Journal:  Int J Cell Biol       Date:  2014-05-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.